Evidence map›Paper›PMID 30108426›Full record

ReviewJournal of the Saudi Heart Association2018

Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis.

Jarrah Alfadhli, Mohammed Jeraq, Vikas Singh, Claudia Martinez

Abstract readReview
In one paragraph

Review in Journal of the Saudi Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jarrah AlfadhliCardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USAUSA.
Mohammed JeraqDepartment of General Surgery, University of Miami Miller School of Medicine, Miami, FL, USAUSA.
Vikas SinghDivision of Cardiology, Massachusetts General Hospital, Boston, MA, USAUSA.
Claudia MartinezCardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USAUSA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned from complications have allowed the evolution of this procedure to the current state. This review focuses on the updates on the most current devices, complications, and outcomes of TAVR.

Indexed as

Aortic stenosisTranscatheter aortic valve implantationTranscatheter aortic valve replacement

Identifiers

PMID30108426
PMCPMC6090012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.